These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20966318)
1. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. Chang IS; Rhim H; Kim SH; Kim YS; Choi D; Park Y; Lim HK AJR Am J Roentgenol; 2010 Nov; 195(5):1131-6. PubMed ID: 20966318 [TBL] [Abstract][Full Text] [Related]
2. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. Kim SH; Lim HK; Choi D; Lee WJ; Kim SH; Kim MJ; Lee SJ; Lim JH AJR Am J Roentgenol; 2004 Dec; 183(6):1611-7. PubMed ID: 15547200 [TBL] [Abstract][Full Text] [Related]
3. Is Antibiotic Prophylaxis for Percutaneous Radiofrequency Ablation (RFA) of Primary Liver Tumors Necessary? Results From a Single-Center Experience. Bhatia SS; Spector S; Echenique A; Froud T; Suthar R; Lawson I; Dalal R; Dinh V; Yrizarry J; Narayanan G Cardiovasc Intervent Radiol; 2015 Aug; 38(4):922-8. PubMed ID: 25392237 [TBL] [Abstract][Full Text] [Related]
4. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Rhim H; Choi D; Kim YS; Lim HK; Choe BK Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152 [TBL] [Abstract][Full Text] [Related]
5. Venous thrombosis after radiofrequency ablation for hepatocellular carcinoma. Kim AY; Rhim H; Park M; Lee MW; Kim YS; Choi D; Lim HK AJR Am J Roentgenol; 2011 Dec; 197(6):1474-80. PubMed ID: 22109305 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma]. Wu J; Chen MH; Yang W; Wu W; Yan K Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144 [TBL] [Abstract][Full Text] [Related]
7. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457 [TBL] [Abstract][Full Text] [Related]
8. Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode. Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Kim SH J Vasc Interv Radiol; 2007 Sep; 18(9):1126-33. PubMed ID: 17804775 [TBL] [Abstract][Full Text] [Related]
9. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance. Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813 [TBL] [Abstract][Full Text] [Related]
10. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. Park JG; Park SY; Tak WY; Kweon YO; Jang SY; Lee YR; Hur K; Lee HJ; Lee HW Clin Radiol; 2017 Aug; 72(8):692.e9-692.e15. PubMed ID: 28364952 [TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach. Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075 [TBL] [Abstract][Full Text] [Related]
12. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy]. Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous endobiliary radiofrequency ablation and stents in management of hepatocellular carcinoma with bile duct tumor thrombus: Initial single-institution experience. Cui W; Xu R; Wang Y; Shi F; Li J; Chen X Asia Pac J Clin Oncol; 2020 Aug; 16(4):259-265. PubMed ID: 32368843 [TBL] [Abstract][Full Text] [Related]